Medtronic Boosts FY23 Adj. EPS Outlook - Update
(RTTNews) - While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) provided its revenue growth guidance for the fourth quarter and raised adjusted earnings outlook for the full-year 2023, based on third quarter performance.
For the fourth quarter, the company expects organic revenue growth of 4.5 to 5.0 percent. Revenue would be negatively affected by approximately $165 million to $215 million at current exchange rates.
For fiscal 2023, the company now projects adjusted earnings in a range of $5.28 to $5.30 per share, up from the prior guidance range of $5.25 to $5.30 per share.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.27 per share for the quarter. Analysts' estimates typically exclude special items.
"As we look ahead, we are focused on delivering durable topline growth and significant expense reductions as we navigate through macro headwinds from foreign currency and inflatio," said Karen Parkhill, Medtronic chief financial officer.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Medtronic Guides FY25 Adj. EPS In Line With Estimates; Boosts Dividend - Update
Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements
Medtronic Boosts FY24 Outlook - Update
Medtronic Says Inceptiv Spinal Cord Stimulator With Closed-loop Sensing Gets CE Mark Approval
Medtronic Guides FY24 Adj. EPS Below View: Boosts Dividend - Update
Medtronic Reiterates FY23 Outlook - Update
Medtronic Inks Co-promotion Deal With Israeli Privately-held Company CathWorks
